Reverse isolation for neutropenic patients

Community Oncology

Volumn 5, Issue 11, 2008, Pages 628-632

  Seshadri, Srividyalakshmi ^a   Baumann, Michael A ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; CANCER CHEMOTHERAPY; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; LAMINAR AIRFLOW; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; PATIENT CARE; REVIEW; SOLID TUMOR; STEM CELL TRANSPLANTATION;

EID: 57149116544     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70529-0     Document Type: Review

References (19)

1. Levine AS, Siegel SE, Schreiber AD, et al. Protected environments and prophylactic antibiotics: a prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 1973;288:477-483.
2. Yates JW, Holland JF. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 1973;32:1490-1498.
3. Schimpff SC, Greene WH, Young VM, et al. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 1975;82:351-358.
4. Dietrich M, Gaus W, Vossen J, van der Waaij D, Wendt F. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection: a prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection 1977;5:107-114.
5. Rodriguez V, Bodey GP, Freireich EJ, et al. Randomized trial of protected environment - prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) 1978;57:253-266.
6. Ribas-Mundo M, Granena A, Rozman C. Evaluation of a protective environment in the management of granulocytopenic patients: a comparative study. Cancer 1981;48:419-424.
7. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448-453.
8. Storring RA, Jameson B, McElwain TJ, Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphohlastic leukaemia. Lancet 1977;2:837-840.
9. Buckner CD, Clift RA, Sanders JE, et al. Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med 1978;89:893-901.
10. Navari RM, Buckner CD, Clift RA, et al. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. Am J Med 1984;76:564-572.
11. Petersen FB, Buckner CD, Clift RA, et al. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand J Infect Dis 1987;19:559-567.
12. Petersen F, Thornquist M, Buckner C, et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 1988;16:199-208.
13. Passweg JR, Rowlings PA, Atkinson KA, et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1998;21:1231-1238.
14. Bodey GP, Rodriguez V, Cabanillas F, Freireich EJ. Protected environment-prophylactic antibiotic program for malignant lymphoma: randomized trial during chemotherapy to induce remission. Am J Med 1979;66:74-81.
15. Bodey GP, Rodriguez V, Murphy WK, Burgess A, Benjamin RS. Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapy. Cancer 1981;47:2422-2429.
16. Hortobagyi GN, Buzdar AU, Bodey GP, et al. High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study. J Clin Oncol 1987;5:178-184.
17. Hortobagyi GN, Bodey GP, Buzdar AU, et al. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clio Oncol 1987;5:354-364.
18. Smith LH, Besser SO. Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum 2000;27:515-520.
19. Moody K, Charlson ME, Finlay J. The neutropenic diet: what's the evidence? J Pediatr Hematol Oncol 2002;24:717-721.